These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34405519)

  • 21. Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Jiang D; Liu XB; Xing WQ; Chen PN; Feng SK; Yan S; Lerut T; Sun HB
    Dis Esophagus; 2023 Apr; 36(5):. PubMed ID: 36385581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
    Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative paratracheal lymph node dissection in left-sided hilar lung cancer patients: comparing the number of lymph nodes dissected to the number of lymph nodes dissected in right-sided mediastinal dissections.
    Toker A; Tanju S; Ziyade S; Kaya S; Erus S; Ozkan B; Yilmazbayhan D
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):974-80. PubMed ID: 21276734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.
    Sun Y; Zhang Q; Wang Z; Shao F
    Thorac Cancer; 2021 May; 12(10):1589-1597. PubMed ID: 33793088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung Cancer.
    Zhu F; Wang H; Ashamalla H
    Clin Lung Cancer; 2022 Sep; 23(6):e384-e393. PubMed ID: 35676168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
    Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
    PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
    Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.
    Isaka M; Kojima H; Imai T; Konno H; Mizuno T; Nagata T; Katsumata S; Kawata T; Nakajima T; Ohde Y
    Gen Thorac Cardiovasc Surg; 2022 Nov; 70(11):977-984. PubMed ID: 35543932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.
    Zhou D; Yue D; Zhang Z; Tian P; Feng Y; Liu Z; Zhang B; Wang M; Zhao X; Wang C
    World J Surg Oncol; 2022 Jul; 20(1):222. PubMed ID: 35778770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
    Ann Surg Oncol; 2021 Nov; 28(12):7162-7171. PubMed ID: 34218364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Implications of Selective Dissection of Left Lower Paratracheal Lymph Nodes in Patients with Left-Sided Non-Small Cell Lung Cancer.
    Park HK; Kwon Y; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Yun JK
    J Chest Surg; 2024 Sep; 57(5):467-476. PubMed ID: 39115199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.